A combination of the CX3CR1 inhibitor with veliparib was strongly synergistic in reducing clone formation in OVCAR-4 and reducing tumor burden in OVCAR-4/athymic nude mouse xenograft experiments. Here, CX3CR1 is linked to neoplasm.